Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F O Nestle

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Dermatology (Basel, Switzerland)|July 2, 2003
Treatment of verrucous carcinoma with imiquimod and CO2 laser ablationL M Heinzerling, W Kempf, J Kamarashev, et al.
The Journal of Investigative Dermatology|July 1, 1995
Direct and indirect control of T-cell activation by keratinocytesB J Nickoloff, L A Turka, R S Mitra, et al.
The British Journal of Dermatology|June 3, 1999
Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndromeT M Fritz, M Kleinhans, F O Nestle, et al.
Therapeutische Umschau. Revue Therapeutique|July 27, 1999
[Vaccination therapy of malignant melanoma]F O Nestle, A Tun Kyi, M Gilliet, et al.
Blood|May 1, 1994
T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28B J Nickoloff, F O Nestle, X G Zheng, et al.
European Journal of Immunology|December 22, 1999
Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturationA Macagno, M Gilliet, F Sallusto, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 4, 2001
[Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid]O P Kreyden, L Borradori, R M Trüeb, et al.
Cellular Immunology|June 1, 1994
Costimulation of superantigen-activated T lymphocytes by autologous dendritic cells is dependent on B7F O Nestle, C Thompson, Y Shimizu, et al.
The American Journal of Pathology|February 1, 1997
Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cellsF O Nestle, G Burg, J Fäh, et al.
Schweizerische Medizinische Wochenschrift|February 22, 1997
[Current therapy concepts in cutaneous T-cell lymphomas]F O Nestle, A C Häffner, M H Schmid, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Dermatology (Basel, Switzerland)|July 2, 2003
Treatment of verrucous carcinoma with imiquimod and CO2 laser ablationL M Heinzerling, W Kempf, J Kamarashev, et al.
The Journal of Investigative Dermatology|July 1, 1995
Direct and indirect control of T-cell activation by keratinocytesB J Nickoloff, L A Turka, R S Mitra, et al.
The British Journal of Dermatology|June 3, 1999
Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndromeT M Fritz, M Kleinhans, F O Nestle, et al.
Therapeutische Umschau. Revue Therapeutique|July 27, 1999
[Vaccination therapy of malignant melanoma]F O Nestle, A Tun Kyi, M Gilliet, et al.
Blood|May 1, 1994
T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28B J Nickoloff, F O Nestle, X G Zheng, et al.
European Journal of Immunology|December 22, 1999
Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturationA Macagno, M Gilliet, F Sallusto, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 4, 2001
[Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid]O P Kreyden, L Borradori, R M Trüeb, et al.
Cellular Immunology|June 1, 1994
Costimulation of superantigen-activated T lymphocytes by autologous dendritic cells is dependent on B7F O Nestle, C Thompson, Y Shimizu, et al.
The American Journal of Pathology|February 1, 1997
Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cellsF O Nestle, G Burg, J Fäh, et al.
Schweizerische Medizinische Wochenschrift|February 22, 1997
[Current therapy concepts in cutaneous T-cell lymphomas]F O Nestle, A C Häffner, M H Schmid, et al.
Pageof 7